🧒 Paediatrics

Epilepsy in Children

Recurrent unprovoked seizures in childhood — most outgrow it with the right diagnosis and treatment.

Overview

Childhood epilepsy affects ~1 in 200 children. Syndromes range from self-limited (childhood absence, BECTS) to severe encephalopathies (Dravet, Lennox–Gastaut). Most children achieve seizure control on first or second medication. Accurate syndrome diagnosis guides drug choice and predicts long-term outcome.

Symptoms

  • • Generalised tonic-clonic, absence or myoclonic seizures
  • • Focal seizures with altered awareness or automatisms
  • • Brief vacant staring with eye flutter (absence)
  • • Post-ictal confusion, headache, sleep
  • • Developmental regression in severe syndromes

Risk factors

  • • Family history of epilepsy
  • • Perinatal hypoxia, prematurity
  • • Febrile seizures (small increase)
  • • Neurodevelopmental disorders

Causes

  • • Genetic: SCN1A (Dravet), CDKL5, channelopathies
  • • Structural: cortical malformation, perinatal stroke, tuberous sclerosis
  • • Metabolic: pyridoxine-dependent, glucose transporter deficiency
  • • Post-infectious or post-traumatic
  • • Idiopathic in many self-limited childhood epilepsies

🚨 Red flags — seek urgent care

  • • Seizure >5 minutes (status epilepticus) — emergency
  • • First seizure with fever in infant <6 months
  • • Focal neurology, papilloedema, head injury
  • • Sudden unexplained loss of consciousness with abnormal movements

When to seek care

  • • Any first unprovoked seizure — same-week paediatric referral
  • • Seizure recurrence, change in pattern, or breakthrough on treatment
  • • Any prolonged seizure — call 999

Diagnosis

  • • Detailed eyewitness history and video where possible
  • • ECG (exclude cardiac syncope), bloods including glucose, calcium, magnesium
  • • EEG within 4 weeks of first seizure; sleep-deprived or prolonged if normal
  • • MRI brain for focal seizures, abnormal exam, or under 2 years
  • • Genetic and metabolic testing for early-onset, drug-resistant, or syndromic presentations

Treatment

  • • First-line by syndrome: ethosuximide (absences), sodium valproate (generalised — avoid in girls of childbearing potential), lamotrigine/levetiracetam (focal/generalised)
  • • Carbamazepine/oxcarbazepine for focal; avoid in juvenile myoclonic epilepsy
  • • Refractory: ketogenic diet, vagus nerve stimulator, epilepsy surgery in selected lesional cases
  • • Rescue medication (buccal midazolam) and individualised seizure plan for school
  • • Cannabidiol for Dravet, Lennox–Gastaut, tuberous sclerosis

Prevention

  • • Antenatal care, immunisations, head-injury prevention
  • • Adherence to medication; avoid sleep deprivation and alcohol in adolescents
  • • Photic-sensitive children: caution with strobe lighting and screens

Complications

  • • Status epilepticus
  • • Sudden Unexpected Death in Epilepsy (SUDEP)
  • • Learning difficulties, behavioural and mental-health comorbidities
  • • Injury during seizures
  • • Medication side effects (cognitive, mood, teratogenicity of valproate)

Prognosis

Around 70% achieve long-term remission. Self-limited childhood epilepsies often resolve in adolescence; severe encephalopathies have guarded prognosis.

Education & self-care

Childhood epilepsy is highly individual. A correct syndrome diagnosis enables the right drug, the right monitoring and a realistic conversation about outlook.

Frequently asked questions

Will my child outgrow epilepsy?

Many will, especially in self-limited syndromes. Outcomes depend on syndrome diagnosis.

Can they go to a normal school?

Yes — most children do, with a written seizure plan and trained staff.

Is medication safe long-term?

Modern AEDs are well tolerated; benefits outweigh small risks. Valproate is avoided in girls and women of childbearing potential.

Medically reviewed by Dr. Handel Emery, MD, FRCP (UK) · Last reviewed 2026-06-08